ConductScience.org, home

Paper698554

Treatment of Raynaud's phenomenon by fibrinolytic enhancement.

Jarrett PE and 2 others. Br Med J, 1978. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. Treatment of Raynaud's phenomenon by fibrinolytic enhancement. Papers, record 698554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/698554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
PubMed
Journal
Br Med J
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
5.46
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jarrett PEP E
2Morland MM
3Browse NLN L

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrinolysisMajor topic
Raynaud DiseaseMajor topic
StanozololMajor topic
Adult
Aged
Blood Flow Velocity
Body Temperature
Female
Hand
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114289442BLOOD VISCOSITY AND RAYNAUD'S DISEASE.Lancet1965https://conductscience.org/library/papers/14289442PubMed
4837170Blood and vein-wall fibrinolytic activity in health and vascular disease.Br Med J1977https://conductscience.org/library/papers/837170PubMed
55429531Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus.Lab Invest1970https://conductscience.org/library/papers/5429531PubMed
65775073Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.Br J Dermatol1969https://conductscience.org/library/papers/5775073PubMed

Download CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
8323396Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.Ann Rheum Dis1993https://conductscience.org/library/papers/8323396PubMed
8079819The differential effects of stanozolol on human skin and synovial fibroblasts in vitro: DNA synthesis and receptor binding.Agents Actions1994https://conductscience.org/library/papers/8079819PubMed
7681375Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.Drugs1993https://conductscience.org/library/papers/7681375PubMed
7427564Treatment of vasospastic disease with prostaglandin E1.Br Med J1980https://conductscience.org/library/papers/7427564PubMed
7259326Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.Ann Rheum Dis1981https://conductscience.org/library/papers/7259326PubMed
6816332Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6816332PubMed
6540787Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.J Clin Pathol1984https://conductscience.org/library/papers/6540787PubMed
6428575Systemic sclerosis: a collagen or microvascular disease?Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6428575PubMed
6350584Systemic sclerosis--a microvascular disorder?J R Soc Med1983https://conductscience.org/library/papers/6350584PubMed
6229551Assessment of platelet function in patients with Raynaud's syndrome.J Clin Pathol1984https://conductscience.org/library/papers/6229551PubMed
2663416Management of Raynaud's phenomenon. Focus on newer treatments.Drugs1989https://conductscience.org/library/papers/2663416PubMed
2556901The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblasts in vitro.Agents Actions1989https://conductscience.org/library/papers/2556901PubMed
2467711Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.BMJ1989https://conductscience.org/library/papers/2467711PubMed
2383084Axillary vein thrombosis in adolescent onset systemic sclerosis.Ann Rheum Dis1990https://conductscience.org/library/papers/2383084PubMed
2285650Pathogenesis and treatment of Raynaud's phenomenon.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2285650PubMed
1994867A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.Ann Rheum Dis1991https://conductscience.org/library/papers/1994867PubMed
1722967A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.Ann Rheum Dis1991https://conductscience.org/library/papers/1722967PubMed
1691027Raynaud's syndrome.BMJ1990https://conductscience.org/library/papers/1691027PubMed
1529798The differential responses of human skin and synovial fibroblasts to stanozolol in vitro: production of prostaglandin E2 and matrix metalloproteinases.Agents Actions1992https://conductscience.org/library/papers/1529798PubMed
1516602Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1516602PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/698554

GET https://conductscience.org/api/papers/v1/698554/cited_by?page=2